Cargando…
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
Liver cancers are the second most frequent cause of global cancer-related mortality of which 90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening programmes for patients with known risk factors, a substantial number of patients are ineligible for curative surgery a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718039/ https://www.ncbi.nlm.nih.gov/pubmed/31528090 http://dx.doi.org/10.3748/wjg.v25.i32.4614 |